CARB-X
@carb-x.bsky.social
A global public-private partnership led by Boston University to fund and support R&D early development of products to combat #antibioticresistance #CARBX
🔗 Visit our website: https://www.carb-x.org
🔗 Visit our website: https://www.carb-x.org
Pinned
CARB-X
@carb-x.bsky.social
· 14d
📢 CARB-X funding round update!
Updated eligibility criteria for cycle two are now available. Review the updated materials to see if your project is eligible. Expressions of Interest may be submitted from 1 Dec. at 10:00 ET – 12 Dec. at 23:59 ET. #IDSky 🧪
🔗 Read here: bit.ly/4dTKvDj
Updated eligibility criteria for cycle two are now available. Review the updated materials to see if your project is eligible. Expressions of Interest may be submitted from 1 Dec. at 10:00 ET – 12 Dec. at 23:59 ET. #IDSky 🧪
🔗 Read here: bit.ly/4dTKvDj
🎧 New podcast!
The CEOs of Centauri Therapeutics and LimmaTech Biologics joined the Optimum Perspectives podcast to talk about the #AMR crisis, emphasizing that sustainable progress requires global, long-term efforts across the ecosystem. #IDSky 🧪
🔗 Listen here: bit.ly/48kDFXk
The CEOs of Centauri Therapeutics and LimmaTech Biologics joined the Optimum Perspectives podcast to talk about the #AMR crisis, emphasizing that sustainable progress requires global, long-term efforts across the ecosystem. #IDSky 🧪
🔗 Listen here: bit.ly/48kDFXk
November 26, 2025 at 2:01 PM
🎧 New podcast!
The CEOs of Centauri Therapeutics and LimmaTech Biologics joined the Optimum Perspectives podcast to talk about the #AMR crisis, emphasizing that sustainable progress requires global, long-term efforts across the ecosystem. #IDSky 🧪
🔗 Listen here: bit.ly/48kDFXk
The CEOs of Centauri Therapeutics and LimmaTech Biologics joined the Optimum Perspectives podcast to talk about the #AMR crisis, emphasizing that sustainable progress requires global, long-term efforts across the ecosystem. #IDSky 🧪
🔗 Listen here: bit.ly/48kDFXk
📢 AMR funding opportunity!
The first @eupohamr.bsky.social funding call is now open. Read the full details of the funding call below. #IDSKy 🧪
🔗 Read here: bit.ly/3Jv877w
🌍 Register for the webinar: bit.ly/4nwcNbk
The first @eupohamr.bsky.social funding call is now open. Read the full details of the funding call below. #IDSKy 🧪
🔗 Read here: bit.ly/3Jv877w
🌍 Register for the webinar: bit.ly/4nwcNbk
The Call is Open!
First #EUPOHAMR joint transnational call for projects explores new treatments to tackle #AMR. The call involves 37 funding organisations from 28 countries w. an estimated call budget of over € 31 million. Co-funded by the #EuropeanUnion.
👉 ohamr.eu/calls/call-2...
First #EUPOHAMR joint transnational call for projects explores new treatments to tackle #AMR. The call involves 37 funding organisations from 28 countries w. an estimated call budget of over € 31 million. Co-funded by the #EuropeanUnion.
👉 ohamr.eu/calls/call-2...
November 25, 2025 at 3:59 PM
📢 AMR funding opportunity!
The first @eupohamr.bsky.social funding call is now open. Read the full details of the funding call below. #IDSKy 🧪
🔗 Read here: bit.ly/3Jv877w
🌍 Register for the webinar: bit.ly/4nwcNbk
The first @eupohamr.bsky.social funding call is now open. Read the full details of the funding call below. #IDSKy 🧪
🔗 Read here: bit.ly/3Jv877w
🌍 Register for the webinar: bit.ly/4nwcNbk
📢 EOI templates for cycle two of the CARB-X 2025 funding round are now available!
Cycle two opens in less than one week. EOI templates give applicants an early look at the questions that will be in the Portal. #IDSky 🧪
🔗 View the templates here: bit.ly/3P56UDB
Cycle two opens in less than one week. EOI templates give applicants an early look at the questions that will be in the Portal. #IDSky 🧪
🔗 View the templates here: bit.ly/3P56UDB
November 25, 2025 at 2:01 PM
📢 EOI templates for cycle two of the CARB-X 2025 funding round are now available!
Cycle two opens in less than one week. EOI templates give applicants an early look at the questions that will be in the Portal. #IDSky 🧪
🔗 View the templates here: bit.ly/3P56UDB
Cycle two opens in less than one week. EOI templates give applicants an early look at the questions that will be in the Portal. #IDSky 🧪
🔗 View the templates here: bit.ly/3P56UDB
Lifeline is coming to London from 28 March – 2 May 2026! Lifeline stars real-life scientists, healthcare workers, and other heroes working to address the #AMR crisis. If you love performing, apply to be in the show! #IDSky
🔗 Apply to be part of Lifeline: bit.ly/4pnViv7
🔗 Apply to be part of Lifeline: bit.ly/4pnViv7
November 24, 2025 at 5:01 PM
Lifeline is coming to London from 28 March – 2 May 2026! Lifeline stars real-life scientists, healthcare workers, and other heroes working to address the #AMR crisis. If you love performing, apply to be in the show! #IDSky
🔗 Apply to be part of Lifeline: bit.ly/4pnViv7
🔗 Apply to be part of Lifeline: bit.ly/4pnViv7
🗞️ New interview!
CARB-X Executive Director and Boston University School of Law professor Kevin Outterson spoke with Infection Control Today to highlight how #AMR is not just a human health crisis, but an economic crisis. #IDSky 🧪
🔗 Watch here: bit.ly/3XJJYxq
CARB-X Executive Director and Boston University School of Law professor Kevin Outterson spoke with Infection Control Today to highlight how #AMR is not just a human health crisis, but an economic crisis. #IDSky 🧪
🔗 Watch here: bit.ly/3XJJYxq
November 24, 2025 at 2:02 PM
🗞️ New interview!
CARB-X Executive Director and Boston University School of Law professor Kevin Outterson spoke with Infection Control Today to highlight how #AMR is not just a human health crisis, but an economic crisis. #IDSky 🧪
🔗 Watch here: bit.ly/3XJJYxq
CARB-X Executive Director and Boston University School of Law professor Kevin Outterson spoke with Infection Control Today to highlight how #AMR is not just a human health crisis, but an economic crisis. #IDSky 🧪
🔗 Watch here: bit.ly/3XJJYxq
🔦 Funding theme spotlight: Seeking diagnostics for typhoid fever for low-resource settings.
There are 11–21M cases of typhoid fever globally each year, mostly among children and in LMICs. #IDSky 🧪
🔗 Learn about our targeted theme + updated eligibility criteria: bit.ly/4dTKvDj
There are 11–21M cases of typhoid fever globally each year, mostly among children and in LMICs. #IDSky 🧪
🔗 Learn about our targeted theme + updated eligibility criteria: bit.ly/4dTKvDj
November 20, 2025 at 4:47 PM
🔦 Funding theme spotlight: Seeking diagnostics for typhoid fever for low-resource settings.
There are 11–21M cases of typhoid fever globally each year, mostly among children and in LMICs. #IDSky 🧪
🔗 Learn about our targeted theme + updated eligibility criteria: bit.ly/4dTKvDj
There are 11–21M cases of typhoid fever globally each year, mostly among children and in LMICs. #IDSky 🧪
🔗 Learn about our targeted theme + updated eligibility criteria: bit.ly/4dTKvDj
🔦Funding theme spotlight: therapeutics for infections caused by Gram-negative pathogens. New antibiotics targeting these bacteria could avert 11.1M #AMR deaths by 2050, especially in LMICs.
🔗Learn about our targeted theme + updated eligibility criteria: bit.ly/4dTKvDj
🔗Learn about our targeted theme + updated eligibility criteria: bit.ly/4dTKvDj
November 19, 2025 at 2:02 PM
🔦Funding theme spotlight: therapeutics for infections caused by Gram-negative pathogens. New antibiotics targeting these bacteria could avert 11.1M #AMR deaths by 2050, especially in LMICs.
🔗Learn about our targeted theme + updated eligibility criteria: bit.ly/4dTKvDj
🔗Learn about our targeted theme + updated eligibility criteria: bit.ly/4dTKvDj
World AMR Awareness Week is November 18th – 24th!
This year’s theme, “Act Now: Protect Our Present, Secure Our Future,” emphasizes the urgency of the antimicrobial resistance crisis and the need for global, united action to address it.
🔗 Learn more: bit.ly/4dTKvDj
This year’s theme, “Act Now: Protect Our Present, Secure Our Future,” emphasizes the urgency of the antimicrobial resistance crisis and the need for global, united action to address it.
🔗 Learn more: bit.ly/4dTKvDj
November 18, 2025 at 2:00 PM
World AMR Awareness Week is November 18th – 24th!
This year’s theme, “Act Now: Protect Our Present, Secure Our Future,” emphasizes the urgency of the antimicrobial resistance crisis and the need for global, united action to address it.
🔗 Learn more: bit.ly/4dTKvDj
This year’s theme, “Act Now: Protect Our Present, Secure Our Future,” emphasizes the urgency of the antimicrobial resistance crisis and the need for global, united action to address it.
🔗 Learn more: bit.ly/4dTKvDj
#GAMRIC2025 conference round-up + new webinar now available!
The inaugural GAMRIC gathered 300+ researchers, funders, and innovators to tackle tough AMR R&D challenges. Catch up on key insights if you couldn't attend GAMRIC or want a recap. #IDSky 🧪
🔗 Read here: bit.ly/47PkTWv
The inaugural GAMRIC gathered 300+ researchers, funders, and innovators to tackle tough AMR R&D challenges. Catch up on key insights if you couldn't attend GAMRIC or want a recap. #IDSky 🧪
🔗 Read here: bit.ly/47PkTWv
November 17, 2025 at 2:00 PM
#GAMRIC2025 conference round-up + new webinar now available!
The inaugural GAMRIC gathered 300+ researchers, funders, and innovators to tackle tough AMR R&D challenges. Catch up on key insights if you couldn't attend GAMRIC or want a recap. #IDSky 🧪
🔗 Read here: bit.ly/47PkTWv
The inaugural GAMRIC gathered 300+ researchers, funders, and innovators to tackle tough AMR R&D challenges. Catch up on key insights if you couldn't attend GAMRIC or want a recap. #IDSky 🧪
🔗 Read here: bit.ly/47PkTWv
📢 CARB-X funding round update!
Updated eligibility criteria for cycle two are now available. Review the updated materials to see if your project is eligible. Expressions of Interest may be submitted from 1 Dec. at 10:00 ET – 12 Dec. at 23:59 ET. #IDSky 🧪
🔗 Read here: bit.ly/4dTKvDj
Updated eligibility criteria for cycle two are now available. Review the updated materials to see if your project is eligible. Expressions of Interest may be submitted from 1 Dec. at 10:00 ET – 12 Dec. at 23:59 ET. #IDSky 🧪
🔗 Read here: bit.ly/4dTKvDj
November 13, 2025 at 3:00 PM
📢 CARB-X funding round update!
Updated eligibility criteria for cycle two are now available. Review the updated materials to see if your project is eligible. Expressions of Interest may be submitted from 1 Dec. at 10:00 ET – 12 Dec. at 23:59 ET. #IDSky 🧪
🔗 Read here: bit.ly/4dTKvDj
Updated eligibility criteria for cycle two are now available. Review the updated materials to see if your project is eligible. Expressions of Interest may be submitted from 1 Dec. at 10:00 ET – 12 Dec. at 23:59 ET. #IDSky 🧪
🔗 Read here: bit.ly/4dTKvDj
CARB-X Interim Chief of R&D Richard Alm, PhD, presented an overview of the #AMR crisis and highlighted CARB-X's work to accelerate novel antibacterial products to address AMR at the @latrobeuni.bsky.social Frontiers in Infectious Diseases Innovation event. #IDSky 🧪
🔗 Watch: bit.ly/3Jz9nGS
🔗 Watch: bit.ly/3Jz9nGS
November 12, 2025 at 2:00 PM
CARB-X Interim Chief of R&D Richard Alm, PhD, presented an overview of the #AMR crisis and highlighted CARB-X's work to accelerate novel antibacterial products to address AMR at the @latrobeuni.bsky.social Frontiers in Infectious Diseases Innovation event. #IDSky 🧪
🔗 Watch: bit.ly/3Jz9nGS
🔗 Watch: bit.ly/3Jz9nGS
The first EUP OHAMR funding call will open Nov. 18, 2025, and close Feb. 2, 2026. A webinar is scheduled for Nov. 26, 2025. CARB-X is proud to be a member of this global partnership. #IDSky 🧪
🔗 Learn more: bit.ly/3Jv877w
🌍 Register for the webinar here: bit.ly/4nwcNbk
🔗 Learn more: bit.ly/3Jv877w
🌍 Register for the webinar here: bit.ly/4nwcNbk
November 11, 2025 at 2:02 PM
The first EUP OHAMR funding call will open Nov. 18, 2025, and close Feb. 2, 2026. A webinar is scheduled for Nov. 26, 2025. CARB-X is proud to be a member of this global partnership. #IDSky 🧪
🔗 Learn more: bit.ly/3Jv877w
🌍 Register for the webinar here: bit.ly/4nwcNbk
🔗 Learn more: bit.ly/3Jv877w
🌍 Register for the webinar here: bit.ly/4nwcNbk
Join CARB-X Alliance Director Vega Masignani, PhD, at I4ID Congress for her keynote lecture “Fighting Antimicrobial Resistance Through Innovation.” #I4ID2025 #IDSky 🧪
📅 November 14
⏰ 9:15 – 9:45 AM CET
🔗 Register here: bit.ly/4qz81MP
📅 November 14
⏰ 9:15 – 9:45 AM CET
🔗 Register here: bit.ly/4qz81MP
November 10, 2025 at 2:01 PM
Join CARB-X Alliance Director Vega Masignani, PhD, at I4ID Congress for her keynote lecture “Fighting Antimicrobial Resistance Through Innovation.” #I4ID2025 #IDSky 🧪
📅 November 14
⏰ 9:15 – 9:45 AM CET
🔗 Register here: bit.ly/4qz81MP
📅 November 14
⏰ 9:15 – 9:45 AM CET
🔗 Register here: bit.ly/4qz81MP
CARB-X Executive Director Kevin Outterson joined the Canadian House of Commons Standing Committee on Science and Research to testify on the #AMR crisis, highlighting the urgent need for both push and pull incentives to support AMR R&D.
🔗 Watch here: bit.ly/4omqE57
🔗 Watch here: bit.ly/4omqE57
November 6, 2025 at 2:12 PM
CARB-X Executive Director Kevin Outterson joined the Canadian House of Commons Standing Committee on Science and Research to testify on the #AMR crisis, highlighting the urgent need for both push and pull incentives to support AMR R&D.
🔗 Watch here: bit.ly/4omqE57
🔗 Watch here: bit.ly/4omqE57
Join CARB-X Senior Alliance Manager Su Chiang, PhD, at the 2nd Annual Antimicrobial Resistance and Infectious Diseases Symposium for her presentation “CARB-X: Stimulating and supporting innovation against AMR.”
📅 Nov. 13
⏰ 9:20 – 9:40 AM ET
🔗 Register here: bit.ly/43z350A
📅 Nov. 13
⏰ 9:20 – 9:40 AM ET
🔗 Register here: bit.ly/43z350A
November 5, 2025 at 2:01 PM
Join CARB-X Senior Alliance Manager Su Chiang, PhD, at the 2nd Annual Antimicrobial Resistance and Infectious Diseases Symposium for her presentation “CARB-X: Stimulating and supporting innovation against AMR.”
📅 Nov. 13
⏰ 9:20 – 9:40 AM ET
🔗 Register here: bit.ly/43z350A
📅 Nov. 13
⏰ 9:20 – 9:40 AM ET
🔗 Register here: bit.ly/43z350A
CARB-X Chief of External Affairs Damiano de Felice, PhD, and other World Economic Forum “What Is the Cost of Underinvesting in Health?” panelists discussed why health should be seen as an investment rather than a cost. #AMGFCC25 #MedSky 🧪
🔗 Watch here: bit.ly/3WKnBrv
🔗 Watch here: bit.ly/3WKnBrv
November 4, 2025 at 2:14 PM
CARB-X Chief of External Affairs Damiano de Felice, PhD, and other World Economic Forum “What Is the Cost of Underinvesting in Health?” panelists discussed why health should be seen as an investment rather than a cost. #AMGFCC25 #MedSky 🧪
🔗 Watch here: bit.ly/3WKnBrv
🔗 Watch here: bit.ly/3WKnBrv
At a recent World Health Summit panel, CARB-X Executive Director Kevin Outterson discussed improving data collection and usage for impactful and accountable AMR policy implementation, including the potential of AI and real-time hospital data. 🧪 #IDSky #WHS2025
🔗 bit.ly/3JauCyw
🔗 bit.ly/3JauCyw
November 3, 2025 at 2:34 PM
At a recent World Health Summit panel, CARB-X Executive Director Kevin Outterson discussed improving data collection and usage for impactful and accountable AMR policy implementation, including the potential of AI and real-time hospital data. 🧪 #IDSky #WHS2025
🔗 bit.ly/3JauCyw
🔗 bit.ly/3JauCyw
CARB-X today announced that Richard Alm, Ph.D., will be appointed as Interim Chief of Research & Development (R&D).
🔗 Read here:
🔗 Read here:
CARB-X APPOINTS DR. RICHARD ALM AS INTERIM CHIEF OF RESEARCH AND DEVELOPMENT - Carb-X
(Boston: October 30, 2025) – Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) today announced that Richard Alm, Ph.D., will be appointed as Interim Chief of Research & Development (R&D). Dr. Alm […]
bit.ly
October 30, 2025 at 1:04 PM
CARB-X today announced that Richard Alm, Ph.D., will be appointed as Interim Chief of Research & Development (R&D).
🔗 Read here:
🔗 Read here:
Attending @bactivac.bsky.social Birmingham? Join CARB-X Alliance Director Ed Buurman, PhD, for his presentation “Supporting AMR Vaccine R&D.” #BactiVacEvents #IDSky
📅 Wednesday, November 5
⏰ 11:15 – 11:45 AM GMT
📅 Wednesday, November 5
⏰ 11:15 – 11:45 AM GMT
October 29, 2025 at 12:51 PM
Attending @bactivac.bsky.social Birmingham? Join CARB-X Alliance Director Ed Buurman, PhD, for his presentation “Supporting AMR Vaccine R&D.” #BactiVacEvents #IDSky
📅 Wednesday, November 5
⏰ 11:15 – 11:45 AM GMT
📅 Wednesday, November 5
⏰ 11:15 – 11:45 AM GMT
CARB-X Executive Director and Boston University School of Law professor Kevin Outterson spoke with The Brink about the latest Global Antibiotic Resistance Surveillance (GLASS) report released by WHO. #IDSky 🧪
🔗 Read here: bit.ly/3WoIUhZ
🔗 Read here: bit.ly/3WoIUhZ
October 28, 2025 at 1:01 PM
CARB-X Executive Director and Boston University School of Law professor Kevin Outterson spoke with The Brink about the latest Global Antibiotic Resistance Surveillance (GLASS) report released by WHO. #IDSky 🧪
🔗 Read here: bit.ly/3WoIUhZ
🔗 Read here: bit.ly/3WoIUhZ
A new article in Science Magazine highlights newly published research and the growing debate about prophylactic use of azithromycin in Africa, which has the potential to save vulnerable children’s lives, but could accelerate antibiotic resistance. #IDSky #MedSky 🧪
🔗 Read here: bit.ly/4hog4I3
🔗 Read here: bit.ly/4hog4I3
October 23, 2025 at 3:01 PM
A new article in Science Magazine highlights newly published research and the growing debate about prophylactic use of azithromycin in Africa, which has the potential to save vulnerable children’s lives, but could accelerate antibiotic resistance. #IDSky #MedSky 🧪
🔗 Read here: bit.ly/4hog4I3
🔗 Read here: bit.ly/4hog4I3
Join CARB-X Director of External Affairs Will Hall at Infection 2025 – @bsacandjac.bsky.social Winter Conference for his presentation “Is anything working? PPP, push pull and nonprofit funding incentives.” #AMGFCC25
📅 Oct. 27
⏰ 9:55 – 10:15 AM GMT
🔗 Register here: bit.ly/4nWRQr7
📅 Oct. 27
⏰ 9:55 – 10:15 AM GMT
🔗 Register here: bit.ly/4nWRQr7
October 23, 2025 at 1:00 PM
Join CARB-X Director of External Affairs Will Hall at Infection 2025 – @bsacandjac.bsky.social Winter Conference for his presentation “Is anything working? PPP, push pull and nonprofit funding incentives.” #AMGFCC25
📅 Oct. 27
⏰ 9:55 – 10:15 AM GMT
🔗 Register here: bit.ly/4nWRQr7
📅 Oct. 27
⏰ 9:55 – 10:15 AM GMT
🔗 Register here: bit.ly/4nWRQr7
Today is #WorldPhageDay, recognizing the potential of bacteriophages to address #AMR. Phages could offer targeted alternatives or complement traditional antibiotics. CARB-X supports phage-based innovation including projects from Locus Biosciences, SNIPR BIOME, and PHIOGEN. #IDSky 🧪
October 22, 2025 at 1:01 PM
Today is #WorldPhageDay, recognizing the potential of bacteriophages to address #AMR. Phages could offer targeted alternatives or complement traditional antibiotics. CARB-X supports phage-based innovation including projects from Locus Biosciences, SNIPR BIOME, and PHIOGEN. #IDSky 🧪
Join CARB-X Chief Scientific Officer Richard Alm, PhD, at the @latrobeuni.bsky.social Frontiers in Infectious Diseases Innovation event for his presentation “CARB-X – Accelerating the Development of Novel Products to Tackle AMR.” #IDSky 🧪
📆 October 29
⏰ 5 – 7 PM AEDT
🔗 Register: bit.ly/3IOo9Jy
📆 October 29
⏰ 5 – 7 PM AEDT
🔗 Register: bit.ly/3IOo9Jy
October 21, 2025 at 1:01 PM
Join CARB-X Chief Scientific Officer Richard Alm, PhD, at the @latrobeuni.bsky.social Frontiers in Infectious Diseases Innovation event for his presentation “CARB-X – Accelerating the Development of Novel Products to Tackle AMR.” #IDSky 🧪
📆 October 29
⏰ 5 – 7 PM AEDT
🔗 Register: bit.ly/3IOo9Jy
📆 October 29
⏰ 5 – 7 PM AEDT
🔗 Register: bit.ly/3IOo9Jy
Congratulations @lumenbio.bsky.social!
CARB-X is proud to have supported LMN-0403, an orally delivered preventative and treatment of diarrheal diseases caused by C. jejuni and enterotoxigenic E. coli, since August 2020.
CARB-X is proud to have supported LMN-0403, an orally delivered preventative and treatment of diarrheal diseases caused by C. jejuni and enterotoxigenic E. coli, since August 2020.
Welcoming Jeff Raikes to our board! https://www.lumen.bio/news/2025/10/08/lumen-bioscience-expands-board-and-leadership-team-to-advance-clinical-pipeline-of-novel-oral-biologics
October 20, 2025 at 12:49 PM
Congratulations @lumenbio.bsky.social!
CARB-X is proud to have supported LMN-0403, an orally delivered preventative and treatment of diarrheal diseases caused by C. jejuni and enterotoxigenic E. coli, since August 2020.
CARB-X is proud to have supported LMN-0403, an orally delivered preventative and treatment of diarrheal diseases caused by C. jejuni and enterotoxigenic E. coli, since August 2020.